The U.S. bioeconomy moves forward (despite of Trump). The University of Arizona has received a five-year grant of up to $15 million from the U.S. Department of Agriculture’s National Institute of Food and Agriculture to lead a new center focusing on the mass production of biofuels and bioproducts in the Southwestern U.S.
Statoil, Shell and Total entered CO2 storage partnership. The three partners aims at maturing the development of carbon storage on the Norwegian continental shelf (NCS). The project is part of the Norwegian authorities’ efforts to develop full-scale carbon capture and storage in Norway.
Italian biochemicals multinational Mossi Ghisolfi is considering selling its Italian business in the biofuels sector as part of a restructuring deal, a source close to the matter said to the International press agency Reuters.
The company, Italy’s second-biggest chemicals business behind that of oil group Eni, has hired Mediobanca to run the process, the source said to Reuters.
A total of eight promising start-ups were invited to pitch at the event “Connecting Bright Innovations 2017” organised by Royal DSM and held this year in Delft (Netherlands), which focused on new and innovative products and biotechnologies for food, health and (bio)tech applications. A panel of expert venturing and innovation specialists is evaluating the pitches with a view to their suitability for further financing and partnering opportunities.
More than 300 delegates from EU, USA, Russia, Turkey, Israel, Latin America and Canada, 40 presentations, 20 scientific posters and a round table on “The role of Shared pilot facilities in fostering the bioeconomy”. These are the numbers of IFIB, the Italian Forum on Industrial Biotechnology and Bioeconomy, which opens today to the world in Rome at Palazzo Rospigliosi.
“Bio-on’s ‘mission’ is to contribute to the protection of ecosystems and natural resources management in an integrated approach, environmentally, economically, socially, technically sustainable”. Marco Astorri, founder and CEO of Bio-on, one of the most dynamic and innovative biotech companies in Europe, talks to Il Bioeconomista. In this long and exclusive interview, the CEO of Bio-on talks about the bioeconomy, the bioplastics and the next steps of the company headquartered in Bologna. “It is necessary – he states – to make a step forward to more circular processes where wastes and co-products of already existing production systems could become raw materials of innovative industrial processes, obtaining added values, reducing emissions and requiring as less oil as possible.”
Interview by Mario Bonaccorso
The demo plant of French company Global Bioenergies, located at the Leuna refinery site, has successfully operated its entire technical process: fermentation, purification, and filling station. The first bottle containing renewable isobutene has been filled.
Tennessee-based Eastman Chemical Company and Origin Materials (formerly known as Micromidas) have entered into a non-exclusive license agreement for Eastman to license its proprietary 2,5-Furandicarboxylic Acid (“FDCA”) and FDCA derivatives production technology from renewable resources to Origin Materials. Origin also recently purchased an oxidation pilot plant from Eastman that will enable Origin to demonstrate the licensed technology. Terms of the license agreement and pilot plant sale were not disclosed.
A new deal in the animal feed sector. Royal DSM, the Dutch global science-based company active in health, nutrition and materials, acquired Twilmij B.V., a well-established Dutch nutritional solutions company in the animal feed sector.
“By taking the time to scale up efficiently and deliberately, our position in the bioeconomy is growing. Circa remains focused on creating non-toxic, high-performance chemicals from cellulose, using our FuracellTM technology. We are targeting a market of over 900,000 tonnes per annum, growing at 4%. While we do not want to compete in the inevitable price war currently unfolding, as companies vie to be ‘last man standing’ to extract some cash out of legacy plants producing these toxic products, we do see plenty of opportunity to sensibly scale into the market over the next 5-10 years”. To say this – in this long, exclusive interview with Il Bioeconomista – is Tony Duncan, CEO of Circa Group, an Australian innovative company which is converting biomass into advanced biochemical materials.
Interview by Mario Bonaccorso